Association of IDH1 mutation with survival of glioma patients in Indonesia

被引：0
|
作者：
Malueka, R. G. [1 ]
Dwianingsih, E. K. [2 ]
Bayuangga, H. F. [1 ]
Argo, I. W. [1 ]
Donurizki, A. D. [1 ]
Shaleh, S. [1 ]
Wicaksono, A. S. [3 ]
Dananjoyo, K. [1 ]
Asmedi, A. [1 ]
Hartanto, R. A. [3 ]
机构：
[1] Nursing Univ Gadjah Mada, Publ Hlth, Dept Neurol, Fac Med, Yogyakarta, Indonesia
[2] Nursing Univ Gadjah Mada, Publ Hlth, Dept Anat Pathol, Fac Med, Yogyakarta, Indonesia
[3] Nursing Univ Gadjah Mada, Publ Hlth, Fac Med, Div Neurosurg,Dept Surg, Yogyakarta, Indonesia
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2019年 / 405卷
关键词：
D O I：
10.1016/j.jns.2019.10.408
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WCN19-1497
引用
收藏
页数：1
相关论文
共 50 条
  • [31] An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
    Marzena Anna Lewandowska
    Jacek Furtak
    Tadeusz Szylberg
    Krzysztof Roszkowski
    Wiesława Windorbska
    Joanna Rytlewska
    Wojciech Jóźwicki
    Molecular Diagnosis & Therapy, 2014, 18 : 45 - 53
  • [32] Mutation Analysis of IDH1 in Paired Gliomas Revealed IDH1 Mutation Was Not Associated with Malignant Progression but Predicted Longer Survival
    Yao, Yu
    Chan, Aden Ka-Yin
    Qin, Zhi Yong
    Chen, Ling Chao
    Zhang, Xin
    Pang, Jesse Chung-Sean
    Li, Hiu Ming
    Wang, Yin
    Mao, Ying
    Ng, Ho-Keung
    Zhou, Liang Fu
    PLOS ONE, 2013, 8 (06):
  • [33] IDH1 mutation diminishes aggressive phenotype in glioma stem cells
    Yao, Qi
    Cai, Gang
    Yu, Qi
    Shen, Jianhong
    Gu, Zhikai
    Chen, Jian
    Shi, Wei
    Shi, Jinlong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (01) : 270 - 278
  • [34] New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
    Dimitrov, Lilia
    Hong, Christopher S.
    Yang, Chunzhang
    Zhuang, Zhengping
    Heiss, John D.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2015, 12 (03): : 201 - 213
  • [35] IDH1 MUTATION REGULATES MYELOID CELLS MEDIATED IMMUNOSUPPRESSION IN GLIOMA
    Alghamri, Mahmoud S.
    Kamran, Neha
    Nunez, Felipe J.
    Lowenstein, Pedro R.
    Castro, Maria G.
    NEURO-ONCOLOGY, 2017, 19 : 125 - 126
  • [36] IDH1 Overexpression Induced Chemotherapy Resistance and IDH1 Mutation Enhanced Chemotherapy Sensitivity in Glioma Cells in Vitro and in Vivo
    Wang, Ju-Bo
    Dong, Dan-Feng
    Wang, Mao-De
    Gao, Ke
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (01) : 427 - 432
  • [37] Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
    Sonoda, Yukihiko
    Kumabe, Toshihiro
    Nakamura, Taigen
    Saito, Ryuta
    Kanamori, Masayuki
    Yamashita, Yoji
    Suzuki, Hiroyoshi
    Tominaga, Teiji
    CANCER SCIENCE, 2009, 100 (10) : 1996 - 1998
  • [38] Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients
    Liu, Xipeng
    Liu, Ming
    Cao, Bing
    Qiao, Jianxin
    Zhang, Xiufeng
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (03) : 843 - 847
  • [39] Association between IDH1/2 mutations and brain glioma grade
    Deng, Lei
    Xiong, Pengju
    Luo, Yunhui
    Bu, Xiao
    Qian, Suokai
    Zhong, Wuzhao
    Lv, Shunqing
    ONCOLOGY LETTERS, 2018, 16 (04) : 5405 - 5409
  • [40] The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
    Malta, Tathiane M.
    Sabedot, Thais S.
    Morosini, Natalia S.
    Datta, Indrani
    Garofano, Luciano
    Vallentgoed, Wies
    Varn, Frederick S.
    Aldape, Kenneth
    D'Angelo, Fulvio
    Bakas, Spyridon
    Barnholtz-Sloan, Jill S.
    Gan, Hui K.
    Hasanain, Mohammad
    Hau, Ann-Christin
    Johnson, Kevin C.
    Cazacu, Simona
    deCarvalho, Ana C.
    Khasraw, Mustafa
    Kocakavuk, Emre
    Kouwenhoven, Mathilde C. M.
    Migliozzi, Simona
    Niclou, Simone P.
    Niers, Johanna M.
    Ormond, D. Ryan
    Paek, Sun Ha
    Reifenberger, Guido
    Sillevis Smitt, Peter A.
    Smits, Marion
    Stead, Lucy F.
    van den Bent, Martin J.
    Van Meir, Erwin G.
    Walenkamp, Annemiek
    Weiss, Tobias
    Weller, Michael
    Westerman, Bart A.
    Ylstra, Bauke
    Wesseling, Pieter
    Lasorella, Anna
    French, Pim J.
    Poisson, Laila M.
    Woehrer, Adelheid
    Verhaak, Roel G. W.
    Iavarone, Antonio
    Noushmehr, Houtan
    CANCER RESEARCH, 2024, 84 (05) : 741 - 756
12345